FDA Heralds The End Of Switching Studies For Biosimilar Interchangeability
Guidance Suggests Analytical And Clinical Data Can Be Sufficient To Support Application
• By David Wallace
The FDA is switching off the requirement for switching studies • Source: Shutterstock 
